155 related articles for article (PubMed ID: 8504509)
1. Risk of stroke in adults with cyanotic congenital heart disease.
Perloff JK; Marelli AJ; Miner PD
Circulation; 1993 Jun; 87(6):1954-9. PubMed ID: 8504509
[TBL] [Abstract][Full Text] [Related]
2. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease.
DeFilippis AP; Law K; Curtin S; Eckman JR
Cardiol Rev; 2007; 15(1):31-4. PubMed ID: 17172881
[TBL] [Abstract][Full Text] [Related]
3. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis.
Rose SS; Shah AA; Hoover DR; Saidi P
J Gen Intern Med; 2007 Dec; 22(12):1775-7. PubMed ID: 17917783
[TBL] [Abstract][Full Text] [Related]
4. Adults with cyanotic congenital heart disease: hematologic management.
Perloff JK; Rosove MH; Child JS; Wright GB
Ann Intern Med; 1988 Sep; 109(5):406-13. PubMed ID: 3044212
[TBL] [Abstract][Full Text] [Related]
5. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease.
Rosove MH; Perloff JK; Hocking WG; Child JS; Canobbio MM; Skorton DJ
Lancet; 1986 Aug; 2(8502):313-5. PubMed ID: 2874330
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease.
Reiss UM; Bensimhon P; Zimmerman SA; Ware RE
Am J Hematol; 2007 Aug; 82(8):740-3. PubMed ID: 17506064
[TBL] [Abstract][Full Text] [Related]
7. Management of polycythaemia in adults with cyanotic congenital heart disease.
Thorne SA
Heart; 1998 Apr; 79(4):315-6. PubMed ID: 9616333
[No Abstract] [Full Text] [Related]
8. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
Broberg CS; Bax BE; Okonko DO; Rampling MW; Bayne S; Harries C; Davidson SJ; Uebing A; Khan AA; Thein S; Gibbs JS; Burman J; Gatzoulis MA
J Am Coll Cardiol; 2006 Jul; 48(2):356-65. PubMed ID: 16843187
[TBL] [Abstract][Full Text] [Related]
9. Hematologic Derangements among Children with Unoperated Cyanotic Congenital Heart Disease in Ethiopia.
Alemseged S; Tefera E
Ethiop J Health Sci; 2023 Nov; 33(6):955-962. PubMed ID: 38784485
[TBL] [Abstract][Full Text] [Related]
10. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
Braun SL; Eicken A; Kaemmerer H
Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular events in adult patients with cyanotic congenital heart disease.
Ammash N; Warnes CA
J Am Coll Cardiol; 1996 Sep; 28(3):768-72. PubMed ID: 8772770
[TBL] [Abstract][Full Text] [Related]
12. A clinico-hematological study of iron deficiency anemia and its correlation with hyperviscosity symptoms in cyanotic congenital heart disease.
Gaiha M; Sethi HP; Sudha R; Arora R; Acharya NR
Indian Heart J; 1993; 45(1):53-5. PubMed ID: 8365742
[TBL] [Abstract][Full Text] [Related]
13. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis.
Gordeuk VR; Key NS; Prchal JT
Haematologica; 2019 Apr; 104(4):653-658. PubMed ID: 30872370
[TBL] [Abstract][Full Text] [Related]
15. Management of polycythaemia in adults with cyanotic congenital heart disease.
Swan L; Hillis WS
Heart; 1999 Apr; 81(4):451. PubMed ID: 10357593
[No Abstract] [Full Text] [Related]
16. Hyperviscosity syndrome revisited.
Gangopadhyay D; Roy M; Laha S; Nandi D; Sengupta R; Chattopadhyay A
Ann Pediatr Cardiol; 2022; 15(3):284-290. PubMed ID: 36589657
[TBL] [Abstract][Full Text] [Related]
17. Headache and papilledema in an adult with cyanotic congenital heart disease: the importance of fundoscopic evaluation rather than phlebotomy.
Loomba RS; Leavitt JA; Cetta F
Congenit Heart Dis; 2012; 7(3):E14-7. PubMed ID: 22070674
[TBL] [Abstract][Full Text] [Related]
18. Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.
Blanche C; Alonso-Gonzalez R; Uribarri A; Kempny A; Swan L; Price L; Wort SJ; Beghetti M; Dimopoulos K
Int J Cardiol; 2018 Sep; 267():79-83. PubMed ID: 29807779
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease.
Oldershaw PJ; Sutton MG
Br Heart J; 1980 Nov; 44(5):584-8. PubMed ID: 7437201
[TBL] [Abstract][Full Text] [Related]
20. [The effect of lowering the hematocrit on polycythemia and thrombocytopenia in congenital cyanotic heart defect].
de Haan M; de Koning J; Ottenkamp J; Schilte PP
Tijdschr Kindergeneeskd; 1985 Oct; 53(5):178-81. PubMed ID: 2418530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
